Alliance Pharma and Ampersand acquire UK-based DDS
AK&M
906
1
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, May 17 agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC
You need to subscribe for access to restricted content.
